These clinical guidelines by the Department of Health aims to strengthen the capacity of the public and private health sectors to deliver high quality integrated health and wellness services; to ensure timely initiation of antiretroviral drugs (ARVs) for treatment and prevention; and to minimize unnecessary drug toxicities in HIV/AIDS patients in South Africa.

These guidelines by the Department of Health outline the necessary TB preventive therapy to ensure better care for people living with HIV/AIDS

This policy by the Department of Health aims to prevent TB as well as ensure that people who do contract TB have easy access to effective, efficient, and high-quality diagnosis, treatment, and care.

The guidelines outline the overarching framework for all matters related to RR-TB management in South Africa.

This policy by the Department of Health aims to prevent TB as well as ensure that people who do contract TB have easy access to effective, efficient, and high-quality diagnosis, treatment, and care.

The overall goal of this policy guidance is for effective clinical management and referral to prevent pregnancy-related deaths and ill health in South Africa.

This strategic plan by the government is based on a 20-year vision for reversing the burden of disease from HIV, STIs, and TB in South Africa and achieving zero HIV and AIDS in South Africa.

This guidance on the management of tuberculosis provides guidelines on the diagnosis of tuberculosis, registration of patients, management of side effects, monitoring treatment, management of TB in pregnancy, and other related matters.

The main objective of this Cancer Strategic Framework is to reduce the impact of cancer on the South African population by mitigating deaths, disability, and financial strain due to cancer through policies aimed at cancer prevention and treatment.

This guidance on the management of tuberculosis in children. The document outlines the guidelines on the diagnosis of tuberculosis, registration of patients, management of side effects, monitoring treatment, and other related matters.

The objectives of this policy are to prevent mortality, prevent disease progression and development of severe malaria, reduce morbidity, eliminate parasitaemia and stop further transmission, to limit the emergence and spread of drug-resistant cases in South Africa.

This policy document on the management of drug-resistant tuberculosis provides guidance on diagnosis, the management of patients, management of drug reactions and recording and reporting, and other special situations.

This policy document on the management of drug-resistant tuberculosis, HIV and sexually transmitted infections. The guidance covers screening, treatment, prevention, mother and child health, recording and reporting, human rights, and other related matters.

This policy document specifies the guidelines for tuberculosis preventive therapy in South Africa. The guidance covers screening, treatment, prevention, monitoring of patients, recording and reporting, and other related matters.

This policy document specifies the guidelines for the treatment of malaria in South Africa. The guidance covers diagnosis, management of severe malaria, treatment of high-risk cases, and other related matters.

The overall objective of these guidelines is to provide healthcare practitioners with information on the best practices for interventions for people working and living in malaria-affected areas.

The primary objective of these policy guidelines is to provide standardized guidance to HCT service providers and to ensure universal high-quality HCT services in South Africa.

This policy aims to guide the public service on the prevention programs and strategies for HIV&AIDS; to provide treatment, care, and support; to manage human, legal rights, and access to justice; and to monitor, research, and surveillance of HIV and Tuberculosis in South Africa.

The objectives of this policy include: to ensure adequate provision of high-quality HTS in South Africa; to ensure the appropriate use of HTS modalities to reach different populations; to strengthen linkages to prevention, care, and treatment services; and to strengthen quality assurance and the delivery of accurate results in HTS.

This guidance provides guidelines for various interventions: nutrition intervention, primary prevention intervention, secondary treatment intervention, and other general matters.